Passions

Trail running

Tennis

Theater

Admissions and credentials

California

New York

Experience

Snowflake Announces $2.3 Billion Convertible Senior Notes Offering

September 27, 2024

Cooley advised Snowflake, the artificial intelligence (AI) Data Cloud company, on its private placement of $2.3 billion aggregate principal amount of convertible senior notes, consisting of $1.15 billion principal amount of convertible senior notes due 2027 and $1.15 billion aggregate principal amount of convertible senior notes due 2029, which includes the exercise in full of the initial purchasers’ options to purchase an additional $150 million principal amount of 2027 notes and $150 million principal amount of 2029 notes. 

Read more

Related contacts

Jon Avina
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Kate Nichols
Partner, Palo Alto
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Eileen Marshall
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Shimeng Cheng
Special Counsel, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Margaret Barreto
Associate, San Francisco
Yoni Horn
Associate, Santa Monica
Talya Kornitzer
Associate, San Francisco
Calvin Lee
Associate, New York
Xueqing Li
Associate, San Francisco
Narmada Murugan
Associate, Palo Alto
Charles A. Watkins II
Associate, Santa Monica
Nicholas Yacoubian
Associate, Palo Alto
Kris Tamashiro
Paralegal Specialist, Palo Alto

Related Practices & Industries

Transact Campus Announces $1.6 Billion Sale to Roper Technologies

August 15, 2024

Cooley advised Reverence Capital Partners’ portfolio company Transact Campus, an innovative campus technology and payment solutions company, on a definitive agreement signed by Reverence Capital Partners to sell Transact to Roper Technologies for $1.6 billion.

Read more

Related contacts

David Silverman
Partner, New York
Izzy Lubarsky
Partner, New York
Dave Young
Partner, Santa Monica
Grigor Lynch
Associate, Colorado
Pat O'Connell
Associate, New York
Matthew Choy
Associate, New York
Eileen Marshall
Partner, Washington, DC
David Dalton
Associate, Santa Monica
Megan Browdie
Partner, Washington, DC
Julia R. Brinton
Associate, Washington, DC
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Santa Monica
Breanna Qin
Associate, Palo Alto
Keith Berets
Partner, Colorado
Tijana Brien
Partner, Palo Alto
Ross Eberly
Partner, Santa Monica
Patrick Flanagan
Partner, New York
Adam Fleisher
Partner, Washington, DC
Todd Gluth
Partner, San Diego
H Joshua Kotin
Partner, Chicago
Mark Lambert
Partner, Palo Alto
Miriam Petrillo
Partner, Chicago
Obrea Poindexter
Partner, Washington, DC
Sean Ruff
Partner, Washington, DC
Ellie Seber
Partner, Santa Monica
Steve Tonsfeldt
Partner, Palo Alto
Jay Vaughan
Partner, Washington, DC
Bryan Berman
Special Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Shimeng Cheng
Special Counsel, San Francisco
David Hopkins
Special Counsel, Colorado
Kristopher Kleiner
Special Counsel, Colorado
Katherine Lee Carey
Special Counsel, San Diego
Stella Sarma
Special Counsel, Brussels
Grant Schweikert
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Steve Andersen
Associate, New York
Chelsea André
Associate, Colorado
Cara Buchicchio
Associate, New York
Umer Chaudhry
Associate, Washington, DC
Norris Kadet
Associate, New York
Allison Kutner
Associate, New York
Calvin Lee
Associate, New York
Eileen Leman
Associate, Los Angeles
Tommi McCarthy
Associate, New York
Zachary Sonenshine
Associate, New York
Stevie Yu
Associate, New York
Andy Zachrich
Associate, San Diego
Patricia Myers
Paralegal Specialist, Colorado
Rebecca Flake
Higher Education Services Advisor, Washington, DC
Brandon Lefebvre
Quantitative Analyst, Boston

Related Practices & Industries

HealthCare Royalty and Blue Owl Announce $250 Million Debt Financing With TG Therapeutics

August 6, 2024

Cooley advised Blue Owl Capital (NYSE: OWL), a top asset manager that is redefining alternatives, and HealthCare Royalty (HCRx), a top royalty acquisition company focused on commercial or near-commercial biopharmaceutical products, on a $250 million term loan facility with TG Therapeutics (NASDAQ: TGTX), a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Addison Pierce
Associate, Chicago
Geoffrey Spolyar
Partner, Boston
Dr. Jon Cousin
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Michael Egan
Partner, Washington, DC
Dr. Heidi A. Erlacher
Partner, Boston
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Jason Savich
Partner, San Francisco
Daniel Shamah
Partner, New York
Lei Shen
Partner, Chicago
Shimeng Cheng
Special Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Amanda Pacheco
Associate, Palo Alto
Dr. Jordan Phelan
Associate, Washington, DC
Matt Kong
Associate, San Francisco
Allison Kutner
Associate, New York
Sarah Miller
Associate, New York
Rodrigo Huerta
Associate, Chicago
Stevie Yu
Associate, New York
Yichao Zhang
Associate, New York

Related Practices & Industries